top of page
Blog
May 9, 20221 min read
Sayuri Miyamoto to present a poster at the Paris Redox 2022 World Conference
NDR is pleased to congratulate Dr. Sayuri Miyamoto and her co-workers Adriano Chaves-Filho, Rosangela Santos, Rodrigo Lima, Larissa...
18
Apr 6, 20223 min read
White Paper Issue 17: Effectiveness of levamisole HCl and thymalfasin in two mouse models of ALS
Levamisole HCl and Zadaxin tested in two mouse models of ALS
37
Mar 8, 20221 min read
Dr. Susanne Petri Joins NDR Scientific Group
NDR Inc is pleased to announce that Dr. Susanne Petri has joined our scientific group. Dr. Petri is an Associate Professor in the...
24
Jan 14, 20221 min read
NDR awards $1.54 M drug development contract to WuXi App Tec
New drug development
38
Jan 10, 20223 min read
NDR White Paper Issue 11: Mechanisms of common pathologies in ALS
Despite the initial cause, all cases of ALS, familial or sporadic, follow a final common pathogenesis. The ability for the body to...
38
Jan 7, 20224 min read
NDR White Paper Issue 10: Genetics and ALS
In Ancient Egypt a person’s essence or soul was passed to their descendants, symbolized by Ka. Amyotrophic lateral sclerosis (ALS) has...
17
Jan 5, 20211 min read
White Paper Issue 9: Stress Response in ALS: Dr. Robert Naviaux
Research in our lab has led to a new understanding of the ancient biology that underlies the circle of injury and recovery. New medicines...
31
bottom of page